Pulmonary embolism in a healthy woman using the oral contraceptives containing desogestrel
Obstetrics & Gynecology Science
;
: 232-235, 2017.
Artigo
em Inglês
| WPRIM
| ID: wpr-223106
ABSTRACT
Venous thromboembolism is well known as one of the rare but serious adverse effects of combined oral contraceptives (COCs). The COCs with third and fourth generation progestogens were found to have higher risk of venous thrombosis than those with second generation progestogens. We present a case of pulmonary embolism in a 23-year-old nulligravid woman who was using COCs containing the third generation progestogen (desogestrel). At the time of presentation of the adverse effect, she had been using the COCs for 4 months. She had no additional risk factors for thrombosis such as smoking, surgery, tumor as well as genetic factors. This case demonstrates even young women in otherwise good health may be at risk of venous thromboembolism from low-dose formulations of COCs as an over-the-counter drug. We describe this case with a brief review of literatures.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Progestinas
/
Embolia Pulmonar
/
Fumaça
/
Trombose
/
Fumar
/
Fatores de Risco
/
Desogestrel
/
Anticoncepcionais Orais
/
Anticoncepcionais Orais Combinados
/
Trombose Venosa
Tipo de estudo:
Estudo de etiologia
/
Fatores de risco
Limite:
Feminino
/
Humanos
Idioma:
Inglês
Revista:
Obstetrics & Gynecology Science
Ano de publicação:
2017
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS